Blood donors needed due to national shortage.  Schedule Now

What's New

June 10, 2021

Blood Donors Needed; Do Your Part

 Schedule Now

Read More
May 10, 2021

Help Us, Help You!

HNL Lab Medicine is excited to share a new Billing Video we put together with our valued clients in mind.  

Read More
April 25, 2021

Governor Tom Wolf honors Medical Lab Professionals Week

In honor of #MedicalLabProfessionalsWeek, Governor Tom Wolf issued a proclamation to recognize the vital role of Pennsylvanians in this field - whether on the front lines with patients, in the clinical lab, or across the many operations essential to diagnosing and treating people! Hear what he had to say to our #healthcareheroes

Read More
April 24, 2021

Healthcare Heroes - Know the Facts

#KnowtheFacts - Although 70% of decisions about patient diagnosis and treatment hinge on laboratory test results, testing still represents only three cents of every dollar spent on healthcare in this country.
Read More
April 23, 2021

Meet our HNL Heroes

Meet our #HNLHeroes!

Read More
Healthcare Professionals

Medicare Test Frequency Limitations

Medicare Test Frequency Limitations

Test Name HNL Test Code CPT Frequency Limitations Descriptions Needs LMN or Supporting DX? Medicare Policy Where to find policy
LIPID PANEL LIPAN 80061 No more than once a year unless with supporting dx  SUPPORTING DX L35099 Lipids Testing
VITAMIN C - ASSAY OF ASCORBIC ACID VITC 82180 Up to 1 times per year without diagnosis limitations applied at this time  LMN L34914 Assays of Vitamins and Metabolic Function
OCCULT BLOOD -
screening
OCBSC 82270 Annually.      
OCCULT BLOOD -
diagnostic
OCCLT 82272 In patients who are taking non-steroidal anti-inflammatory drugs and have a history of gastrointestinal bleeding but no other signs, symptoms, or complaints associated with gastrointestinal blood loss, testing for occult blood may generally be appropriate no more than once every three months. BOTH 190.34 Fecal Occult Blood Test
VITAMIN D; 25
HYDROXY
VTD 82306 Up to 3 times per year with supporting dx  BOTH L34914 Assays of Vitamins and Metabolic Function
CARCINOEMBRYONIC ANTIGEN (CEA) CEA 82378 Serum CEA determinations are generally not indicated more frequently than once per chemotherapy treatment cycle for patients with metastatic solid tumors which express CEA or every two months post-surgical treatment for patients who have had colorectal carcinoma. However, it may be proper to order the test more frequently in certain situations, for example, when there has been a significant change from prior CEA level or a significant change in patient status which could reflect disease progression or recurrence. Testing with a diagnosis of an in situ carcinoma is not reasonably done more frequently than once, unless the result is abnormal, in which case the test may be repeated once. BOTH 190.26 Carcinoembryonic Antigen
ASSAY OF CARNITINE CARN &
UCAR
82379 Up to 3 times per year with supporting dx  BOTH L34914 Assays of Vitamins and Metabolic Function
CHOLESTEROL CHOL 82465 No more than every 2 months unless with supporting dx SUPPORTING DX L35099 Lipids Testing
COLLAGEN NTx X-LINK CNTXL 82523 Because of significant specimen to specimen collagen crosslink physiologic variability (15-20%), current recommendations for appropriate utilization include: one or two base-line assays from specified urine collections on separate days; followed by a repeat assay about 3 months after starting anti-resorptive therapy; followed by a repeat assay in 12 months after the 3-month assay; and thereafter not more than annually, unless there is a change in therapy in which circumstance an additional test may be indicated 3 months after the initiation of new therapy. BOTH 190.19 Collagen Crosslinks, Any Method
VITAMIN B12 VB12, ANCP2, VB12STAT 82607 Up to 2 times per year with supporting dx  BOTH L34914 Assays of Vitamins and Metabolic Function
VITAMIN D; 1, 25
DIHYDROXY
VD1 82652 Up to 2 times per year with supporting dx  BOTH L34914 Assays of Vitamins and Metabolic Function
ASSAY OF FOLIC ACID SERUM FOLATE, ANCP2 82746 Up to 3 times per year with supporting dx  BOTH L34914 Assays of Vitamins and Metabolic Function
REAGENT STRIP/BLOOD GLUCOSE HNL DOES NOT PERFORM 82948 Once per month unless with supporting dx  SUPPORTING DX L35099 Lipids Testing
GLUCOSE BLOOD TEST HNL DOES NOT PERFORM 82962 Once per month unless with supporting dx  SUPPORTING DX L35099 Lipids Testing
GAMMA GT GGT 82977 When used to assess liver dysfunction secondary to existing non-hepatobiliary disease with no change in signs, symptoms, or treatment, it is generally not necessary to repeat a GGT determination after a normal result has been obtained unless new indications are present. If the GGT is the only “liver” enzyme abnormally high, it is generally not necessary to pursue further evaluation for liver disease for this specific indication. When used to determine if other abnormal enzyme tests reflect liver abnormality rather than other tissue, it generally is not necessary to repeat a GGT more than one time per week. BOTH 190.32 Gamma Glutamyl Transferase
FRUCTOSAMINE FRUC 82985 Once per month  LMN L35099 Lipids Testing
HEMOGLOBIN A1c HA1CG 83036 Once per month  LMN L35099 Lipids Testing
ASSAY OF HOMOCYSTEINE HCYS, CVCP3, HCCP1 83090 Up to 1 times per year with supporting dx  BOTH L34914 Assays of Vitamins and Metabolic Function
ASSAY LIPOPROTEIN PLA2 MCHG83698 83698 Up to 1 times per year with supporting dx  BOTH L34914 Assays of Vitamins and Metabolic Function
HDL CHOLESTEROL,DIR HDLD 83718 No more than every 2 months unless with supporting dx  SUPPORTING DX L35099 Lipids Testing
LDL CHOLESTEROL,
DIRECT
LDL 83721 No more than every 2 months unless with supporting dx  SUPPORTING DX L35099 Lipids Testing
PSA,TOTAL,
PROSTATE SPECIFIC
ANTIGEN - diagnostic
PSA 84153 Generally, for patients with lower urinary tract signs or symptoms, the test is performed only once per year unless there is a change in the patient’s medical condition. Testing with a diagnosis of in situ carcinoma is not reasonably done more frequently than once, unless the result is abnormal, in which case the test may be repeated once.      
ASSAY OF VITAMIN B6 VTB6 84207 Up to 1 times per year with supporting dx  BOTH L34914 Assays of Vitamins and Metabolic Function
ASSAY OF VITAMIN B2 VITB2 84252 Up to 1 times per year without diagnosis limitations applied at this time  LMN L34914 Assays of Vitamins and Metabolic Function
ASSAY OF VITAMIN B1 VB1, WBVB1 84425 Up to 1 times per year without diagnosis limitations applied at this time  LMN L34914 Assays of Vitamins and Metabolic Function
T4, THYROXINE;
TOTAL
TH7 84436 Up to 4 times per year for most patients,  unless with supporting dx  SUPPORTING DX L35099 Lipids Testing
T4 FREE,
THYROXINE; FREE
FT4 84439 Up to 4 times per year for most patients,  unless with supporting dx  SUPPORTING DX L35099 Lipids Testing
THYROID
STIMULATING
HORMONE (TSH)
TSH 84443 Up to 4 times per year for most patients,  unless with supporting dx  SUPPORTING DX L35099 Lipids Testing
ASSAY OF VITAMIN E VAECP, VITAE 84446 Up to 1 times per year without diagnosis limitations applied at this time LMN L34914 Assays of Vitamins and Metabolic Function
TRIGLYCERIDE TRIG 84478 No more than every 2 months unless with supporting dx  SUPPORTING DX L35099 Lipids Testing
T3, Uptake T3U 84479 Up to 4 times per year for most patients,  unless with supporting dx  SUPPORTING DX L35099 Lipids Testing
ASSAY OF VITAMIN A VAECP, VITAB 84590 Up to 1 times per year without diagnosis limitations applied at this time  LMN L34914 Assays of Vitamins and Metabolic Function
ASSAY OF VITAMIN K VITK 84597 Up to 1 times per year without diagnosis limitations applied at this time  LMN L34914 Assays of Vitamins and Metabolic Function
BETA HCG, SERUM BHCGH 84702 It is not reasonable and necessary to perform hCG testing more than once per month for diagnostic purposes. It may be performed as needed for monitoring of patient progress and treatment. Qualitative hCG assays are not appropriate for medically managing patients with known or suspected germ cell neoplasms. BOTH 190.27 Human Chorionic Gonadotropin
FIBRONOGEN ANTIGEN   85385 Up to 3 times per year with supporting dx  BOTH L34914 Assays of Vitamins and Metabolic Function
ALLERGEN IGE Various Codes 86003 CPT code 86003 will be covered for only thirty (30) units in a year. BOTH L36241 Allergy Testing
C-REACTIVE PROTEIN
HIGH SENSITIVITY TESTING
HSCRP 86141 It is considered reasonable and necessary to perform no more than 3 hsCRP services per patient lifetime. BOTH L34856 C-Reactive Protein High Sensitivity Testing (hsCRP)
HUMAN
PAPILLOMAVIRUS
HPV 87624 HPV testing once every five years as an additional preventive service benefit under the Medicare program for asymptomatic beneficiaries aged 30 to 65 years in conjunction with the Pap smear test. (Use ICD-10 code Z12.4 and Z11.51).      
GLUCOSE TESTS FOR
DIABETIC SCREENING
  82947
82950
82951
Two screening tests per year for beneficiaries diagnosed with pre-diabetes. One screening test per year if previously tested, but not diagnosed with prediabetes, or if never tested. (Use ICD-10 code Z13.1).     Diabetes Screening
PSA, TOTAL,
PROSTATE SPECIFIC
ANTIGEN - screening
PSAST G0103 Annually. All male Medicare beneficiaries aged 50 and older (coverage begins the day after 50th birthday, Z12.5)   NCD 210.1 National Coverage Determination (NCD) for Prostate Cancer Screening Tests 
PAP SCREEN N/A G0123
G0145
P3000
Annually if at high risk for developing cerv or vag CA, or childbearing age with abnormal PAP within past 3 yrs, every 24 months for all other women. (Use ICD-10 codes: High risk – Z77.22, Z77.9, Z91.89, Z72.89, Z72.51, Z72.52, AND Z72.53 / Low risk – Z01.411, Z01.419, Z12.4, Z12.72, Z12.79, and Z12.89).   NCD 210.2 National Coverage Determination (NCD) for Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer 
HPV SCREEN N/A G0476 Once every 5 years   NCD 210.2.1 Screening for Cervical Cancer with Human Papillomavirus
(HPV) Tests